High tumor budding predicts a poor prognosis in resected duodenal adenocarcinoma

被引:4
|
作者
Sakaguchi, Tatsuma [1 ]
Satoi, Sohei [1 ]
Hashimoto, Daisuke [1 ]
Yamamoto, Tomohisa [1 ]
Yamaki, So [1 ]
Hirooka, Satoshi [1 ]
Ishida, Mitsuaki [2 ]
Ikeura, Tsukasa [3 ]
Inoue, Kentaro [1 ]
Naganuma, Makoto [3 ]
Ishikawa, Hideki [4 ]
Sekimoto, Mitsugu [1 ]
机构
[1] Kansai Med Univ, Dept Surg, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan
[2] Kansai Med Univ, Dept Pathol & Clin Lab, Osaka, Japan
[3] Kansai Med Univ, Dept Internal Med 3, Osaka, Japan
[4] Kyoto Prefectural Univ Med, Dept Mol Targeting Canc Prevent, Kyoto, Japan
关键词
Duodenal adenocarcinoma; Tumor budding; Prognosis; Curative resection; Recurrence pattern; COLORECTAL-CANCER; SURVIVAL;
D O I
10.1007/s00595-021-02433-z
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose Tumor budding is a histological characteristic defined as the presence of small clusters of cancer cells at the invasion front. Its significance in duodenal adenocarcinoma (DA) has not been fully described. Methods A single-center, retrospective study was conducted. Patients who underwent curative surgery for histologically diagnosed DA from January 2006 to December 2018 at Kansai Medical University Hospital were included. Tumor budding was counted per 0.785 mm(2) and classified as low (0-4 buds), intermediate (5-9 buds), or high (>= 10 buds). Results In total, 47 patients were included. The 5-year overall survival and relapse-free survival rates were 77% and 72%, respectively. High tumor budding was seen in 15 patients (32%). Excluding patients with superficial type (pT1) DA (n = 22), high tumor budding [hazard ratio (HR) 13.4, p = 0.028], regional lymph node metastasis (HR 19.9, p = 0.039), and adjuvant chemotherapy (HR 0.056, p = 0.036) were independent factors related to the overall survival in multivariate analyses. Distant metastases occurred significantly more often in patients who had high tumor budding than in others (p = 0.039). Conclusion The data suggest that high tumor budding is a predictor of a poor prognosis in resected DA.
引用
收藏
页码:931 / 940
页数:10
相关论文
共 50 条
  • [1] High tumor budding predicts a poor prognosis in resected duodenal adenocarcinoma
    Tatsuma Sakaguchi
    Sohei Satoi
    Daisuke Hashimoto
    Tomohisa Yamamoto
    So Yamaki
    Satoshi Hirooka
    Mitsuaki Ishida
    Tsukasa Ikeura
    Kentaro Inoue
    Makoto Naganuma
    Hideki Ishikawa
    Mitsugu Sekimoto
    Surgery Today, 2022, 52 : 931 - 940
  • [2] Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma
    Lohneis, Philipp
    Hieggelke, Lena
    Gebauer, Florian
    Ball, Markus
    Bruns, Christiane
    Buettner, Reinhard
    Loeser, Heike
    Quaas, Alexander
    VIRCHOWS ARCHIV, 2021, 478 (03) : 393 - 400
  • [3] Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma
    Philipp Lohneis
    Lena Hieggelke
    Florian Gebauer
    Markus Ball
    Christiane Bruns
    Reinhard Büttner
    Heike Löser
    Alexander Quaas
    Virchows Archiv, 2021, 478 : 393 - 400
  • [4] Tumor Budding and Prognosis in Gastric Adenocarcinoma
    Kemi, Niko
    Eskuri, Maarit
    Ikalainen, Julia
    Karttunen, Tuomo J.
    Kauppila, Joonas H.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2019, 43 (02) : 229 - 234
  • [5] High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma
    Hoda, Mir Alireza
    Rozsas, Anita
    Lang, Elisabeth
    Klikovits, Thomas
    Lohinai, Zoltan
    Torok, Szilvia
    Berta, Judit
    Bendek, Matyas
    Berger, Walter
    Hegedus, Balazs
    Klepetko, Walter
    Renyi-Vamos, Ferenc
    Grusch, Michael
    Dome, Balazs
    Laszlo, Viktoria
    ONCOTARGET, 2016, 7 (12) : 13388 - 13399
  • [6] A combination of tumor and molecular markers predicts a poor prognosis in lung adenocarcinoma
    Liu, Changxu
    Huang, Qiujuan
    Ma, Wenjuan
    Qi, Lisha
    Wang, Yalei
    Qu, Tonguan
    Sun, Leina
    Sun, Baocun
    Meng, Bin
    Cao, Wenfeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (05): : 1690 - 1701
  • [7] High expression of DEK predicts poor prognosis of gastric adenocarcinoma
    Piao, Junjie
    Shang, Yongjun
    Liu, Shuangping
    Piao, Yingshi
    Cui, Xuelian
    Li, Yuzi
    Lin, Zhenhua
    DIAGNOSTIC PATHOLOGY, 2014, 9
  • [8] High expression of DEK predicts poor prognosis of gastric adenocarcinoma
    Junjie Piao
    Yongjun Shang
    Shuangping Liu
    Yingshi Piao
    Xuelian Cui
    Yuzi Li
    Zhenhua Lin
    Diagnostic Pathology, 9
  • [9] Coexpression of EGFR and CXCR4 Predicts Poor Prognosis in Resected Pancreatic Ductal Adenocarcinoma
    Wu, Huanwen
    Zhu, Liang
    Zhang, Hui
    Shi, Xiaohua
    Zhang, Li
    Wang, Wenze
    Xue, Huadan
    Liang, Zhiyong
    PLOS ONE, 2015, 10 (02):
  • [10] KRAS G>A mutation favors poor tumor differentiation but may not be associated with prognosis in patients with curatively resected duodenal adenocarcinoma
    Fu, Tao
    Guzzetta, Angela A.
    Jeschke, Jana
    Vatapalli, Rajita
    Dave, Pujan
    Hooker, Craig M.
    Morgan, Richard
    Iacobuzio-Donahue, Christine A.
    Liu, Baohua
    Ahuja, Nita
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (11) : 2502 - 2509